{
    "code": "56026509",
    "url": "https:\/\/www.fda.gov.tw\/MLMS\/H0001D.aspx?Type=Lic&LicId=56026509",
    "time": "2019-05-24 03:52:22",
    "許可證字號": "衛部醫器輸字第026509號",
    "註銷狀態": "",
    "註銷日期": "",
    "註銷理由": "",
    "有效日期": "113\/08\/14",
    "發證日期": "103\/08\/14",
    "許可證種類": "醫　器",
    "舊證字號": "",
    "醫療器材級數": "第二等級",
    "通關簽審文件編號": "DHA05602650907",
    "中文品名": "錄秘帕斯異常凝血酶原和涎液化糖鏈抗原對照品",
    "英文品名": "Lumipulse PIVKA-II and KL-6 Controls",
    "效能": "使用錄秘帕斯系統分析異常凝血酶原和涎液化糖鏈抗原時，用於監控實驗測試程序準確性之品管血清。",
    "醫器規格": "233801。",
    "劑型": "",
    "包裝": "",
    "標籤、仿單及包裝加註": "",
    "": "",
    "醫器主類別一": "A臨床化學及臨床毒理學",
    "醫器次類別一": "A1660品管材料(分析與非分析)",
    "醫器主類別二": "",
    "醫器次類別二": "",
    "醫器主類別三": "",
    "主成分略述": [
        ""
    ],
    "限制項目": "02輸　入",
    "申請商名稱": "1401804200  台富製藥股份有限公司",
    "主製造廠": {
        "主製造廠": "",
        "製造廠名稱": "MJP0420300  FUJIREBIO INC., HACHIOJI FACILITY",
        "製造廠廠址": "51 KOMIYA-CHO, HACHIOJI-SHI, TOKYO 192-0031, JAPAN",
        "製造廠公司地址": "",
        "": ""
    },
    "藥理治療分類": "",
    "ingredients": [],
    "仿單外盒": [
        {
            "title": "560265090001-103-09-17.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=56026509&Seq=001&Type=9"
        },
        {
            "title": "560265090002--103-09-17.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=56026509&Seq=001&Type=8"
        }
    ]
}